P8A:SGX
Cordlife Group Ltd
SGD 0,12
0,00%
(0,00) 1D
12 ຕ.ລ., 9 ໂມງ 49 ນາທີ 20 ວິນາທີ GMT+8 · SGD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for P8A...
Mkt. cap
32,37 ລ້ານ
Avg. vol.
1,32 ພັນ
Volume
0,00
52-wk high
SGD 0,26
52-wk low
SGD 0,10
EPS
SGD-0,04
Shares outstanding
267,53 ລ້ານ
No. of employees
111
Mkt. cap
32,37 ລ້ານ
Avg. vol.
1,32 ພັນ
Volume
0,00
52-wk high
SGD 0,26
52-wk low
SGD 0,10
EPS
SGD-0,04
Shares outstanding
267,53 ລ້ານ
No. of employees
111
News stories
From web sources and news partners
Simply Wall Street
·
5 ນາທີກ່ອນ
Did Genetic Response Data Just Shift Madrigal Pharmaceuticals (MDGL) Investment Narrative?
MarketWatch
·
17 ນາທີກ່ອນ
It was another great week for the average stock as market leadership shifts away from tech
Moneycontrol.com
·
41 ນາທີກ່ອນ
Polymarket sees 31% chance of S&P 500 hitting 8,000 by year-end
CNN
·
16 ຊົ່ວໂມງກ່ອນ
Nasdaq sinks more than 2% as investors raise questions about AI debt
Profile
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
About Cordlife Group Ltd
CEOYiu Pang Fai
Employees111
Founded2 ພ.ພ. 2001
Headquarters-
SectorHealth care provider
Websitecordlife.com